Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T69797 |
ETX0282
|
Others | Others |
ETX0282 is an orally available, broad spectrum inhibitor of class A and C β-lactamases. Entasis is developing ETX0282 in combination with cefpodoxime proxetil, an orally available cephalosporin approved for treatment of a variety of bacterial infections. | |||
T69796 |
Nevirapine hemihydrate
|
Others | Others |
Nevirapine hemihydrate is a non-nucleoside reverse transcriptase inhibitor (NNRTI) studied for potential treatment of HIV-1 infection and AIDS. |